Illustrative

GLP-1s More Effective at Preventing Colorectal Cancer Than Aspirin

AJMC·Jan 6

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Research suggests that GLP-1s may be more effective at preventing colorectal cancer than aspirin. This finding indicates a potential benefit of GLP-1s in reducing the risk of this type of cancer. The comparison between GLP-1s and aspirin in terms of colorectal cancer prevention has yielded results that favor GLP-1s.

Full coverage

Weighing the Evidence Supporting Aspirin vs GLP-1 RAs in Colorectal Cancer Prevention

The ASCO Post·Jun 10

GLP-1s outdo aspirin in colorectal cancer prevention, study finds | 2026 ASCO Gastrointestinal Cancers Symposium

Managed Healthcare Executive·Jan 5

GLP-1 Agents vs Aspirin: A New Era in Colorectal Cancer Prevention

Oncodaily·Jan 23

GLP-1 Receptor Agonists Show Potential Relative Reduction in CRC Incidence Compared With Aspirin

ASCO Daily News·Jan 5

Could GLP-1s have an impact on colon cancer risk? New data is promising.

NOLA.com·Mar 22

Scientists Find Popular Medication for Colon Cancer Prevention May Do More Harm Than Good

Prevention·Mar 9

Yes, Aspirin Does Prevent Cancer. Just Not Fast Enough.

Medscape·Sep 26

Do You Actually Need That Daily Aspirin You're Taking?

Verywell Health·Mar 11

View original report at AJMC ↗

Fetching the latest headlines…